Paper4584033
Nitrosoureas in central nervous system tumors.
Walker MD. Cancer Chemother Rep 3, 1973. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Nitrosoureas in central nervous system tumors. Papers, record 4584033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Brain Neoplasms | Major topic |
| Carmustine | Major topic |
| Glioma | Major topic |
| Nitrosourea Compounds | Major topic |
| Cyclohexanes | |
| Humans | |
| Injections, Intravenous | |
| Time Factors |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6446427 | Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6446427 | PubMed |
| 6227420 | Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6227420 | PubMed |
| 3971480 | Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3971480 | PubMed |
| 3377683 | CCNU-adriamycin association induces earlier and more severe nephropathy in rats. | Arch Toxicol | 1988 | https://conductscience.org/library/papers/3377683 | PubMed |
| 3260820 | Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3260820 | PubMed |
| 2358844 | Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique. | J Neurooncol | 1990 | https://conductscience.org/library/papers/2358844 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
| 1280536 | Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1280536 | PubMed |
| 696446 | Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation. | Acta Neurochir (Wien) | 1978 | https://conductscience.org/library/papers/696446 | PubMed |
| 468898 | Brain tumor chemotherapy using a rat glioma model. | J Cancer Res Clin Oncol | 1979 | https://conductscience.org/library/papers/468898 | PubMed |
| 356524 | Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds. | Acta Neurochir (Wien) | 1978 | https://conductscience.org/library/papers/356524 | PubMed |
| 188658 | Extracerebrospinal metastases in glioblastoma. Case report and review of the literature. | Eur J Pediatr | 1977 | https://conductscience.org/library/papers/188658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4584033
GET https://conductscience.org/api/papers/v1/4584033/authors